Does OLAPARIB Cause Acute myeloid leukaemia? 330 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 330 reports of Acute myeloid leukaemia have been filed in association with OLAPARIB (Lynparza). This represents 1.8% of all adverse event reports for OLAPARIB.
330
Reports of Acute myeloid leukaemia with OLAPARIB
1.8%
of all OLAPARIB reports
137
Deaths
119
Hospitalizations
How Dangerous Is Acute myeloid leukaemia From OLAPARIB?
Of the 330 reports, 137 (41.5%) resulted in death, 119 (36.1%) required hospitalization, and 102 (30.9%) were considered life-threatening.
Is Acute myeloid leukaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 330 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Acute myeloid leukaemia?
CYCLOPHOSPHAMIDE (1,675)
VENETOCLAX (1,591)
DOXORUBICIN (1,503)
AZACITIDINE (1,156)
ETOPOSIDE (1,069)
VINCRISTINE (984)
CYTARABINE (837)
CARBOPLATIN (812)
RITUXIMAB (735)
METHOTREXATE (728)
Which OLAPARIB Alternatives Have Lower Acute myeloid leukaemia Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL